Search Login Register
Amaurosis Fugax
Summary
160
relevant articles (2 outcomes,
11 trials/studies)
found for this Disease
Description:
Transient complete or partial monocular blindness due to retinal ischemia. This may be caused by emboli from the CAROTID ARTERY (usually in association with CAROTID STENOSIS) and other locations that enter the central RETINAL ARTERY. (From Adams et al., Principles of Neurology, 6th ed, p245)
Also Known As:
Blindness, Transient Monocular; Transient Monocular Blindness; Blindness, Monocular, Transient; Monocular Blindness, Transient
Key Drugs and Agents for Amaurosis Fugax
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Retinaldehyde (Retinal)
:
1 outcome 3 studies in 53 results
: IBA
-
Aspirin (Acetylsalicylic Acid)
:
3 studies in 18 results
:
FDA 77
Generic
-
Ticlopidine (Ticlid)
:
1 study in 3 results
:
FDA 11
Generic
-
glucuronyl glucosamine glycan sulfate (Vessel)
:
1 study in 3 results
: IBA
-
Oral Contraceptives
:
1 study in 2 results
: IBA
-
Cytokines
:
1 study in 1 result
: IBA
-
indobufen
:
1 study in 1 result
: IBA
-
Antiphospholipid Antibodies
:
7 results
: IBA
-
Fluorescein (Funduscein)
:
4 results
:
FDA 2
-
Fibrin
:
4 results
: IBA
Show All >>
Diseases Related to Amaurosis Fugax
-
Ischemia
-
Stroke (Strokes)
-
Transient Ischemic Attack
-
Pathologic Constriction (Stenosis)
-
Infarction
Show All >>
Key Therapies for Amaurosis Fugax
Efficacy Chart >>
-
Endarterectomy (Thromboendarterectomy)
:
1 outcome 1 study in 12 results
-
Carotid Endarterectomy
:
3 studies in 31 results
-
Transplants (Transplant)
:
3 results
-
Angioplasty (Angioplasties)
:
2 results
-
Neck Dissection (Radical Neck Dissection)
:
1 result
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.